Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$559K Buy
19,395
+8,772
+83% +$196K ﹤0.01% 1610
2026
Q1
$180K Buy
+10,623
New +$228K ﹤0.01% 1900
2025
Q3
Sell
-27,012
Closed -$574K 1661
2025
Q2
$574K Buy
27,012
+15,593
+137% +$342K ﹤0.01% 1336
2025
Q1
$264K Buy
11,419
+5,817
+104% +$125K ﹤0.01% 1622
2024
Q4
$102K Buy
+5,602
New +$86.9K ﹤0.01% 1793
2024
Q2
Sell
-8,740
Closed -$279K 2020
2024
Q1
$279K Hold
8,740
﹤0.01% 1561
2023
Q4
$329K Buy
8,740
+4,237
+94% +$142K ﹤0.01% 1516
2023
Q3
$149K Hold
4,503
﹤0.01% 1669
2023
Q2
$174K Hold
4,503
﹤0.01% 1641
2023
Q1
$140K Sell
4,503
-331
-7% -$10.9K ﹤0.01% 1667
2022
Q4
$158K Sell
4,834
-275
-5% -$9.94K ﹤0.01% 1544
2022
Q3
$205K Hold
5,109
﹤0.01% 1451
2022
Q2
$148K Hold
5,109
﹤0.01% 1395
2022
Q1
$239K Sell
5,109
-432
-8% -$18.5K ﹤0.01% 1368
2021
Q4
$243K Hold
5,541
﹤0.01% 1471
2021
Q3
$310K Buy
+5,541
New +$306K ﹤0.01% 1398

Other funds holding PGNY

Amundi's PGNY Position: Q2 2026 in Review

Amundi increased its Progyny (PGNY) stake by 83% in Q2 2026, buying an estimated $196K and bringing the position to 19,395 shares worth $559K. The position accounts for ﹤0.01% of the portfolio, ranked #1610.

Amundi first reported a position in PGNY in Q3 2021 and has held it in 16 quarters since. The position peaked at $574K in Q2 2025. 311 funds tracked by Wall St. Rank hold PGNY as of Q2 2026.

  • Amundi held 19,395 shares of Progyny worth $559K as of Q2 2026.
  • Amundi bought 8,772 Progyny shares in Q2 2026, an estimated $196K.
  • Progyny made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1610 holding.
  • Amundi first reported a position in Progyny in Q3 2021 and has held it in 16 quarters since.
  • Amundi's Progyny position peaked at $574K in Q2 2025.
  • 311 funds tracked by Wall St. Rank held Progyny as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.